SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1560Will there be a FDA panel prior to the Aug 4th PDUFA date for Zaltrap? Just looFelix B-5/30/2012
1559finance.yahoo.com Sanofi and Regeneron Announce Publication of Positive Phase 2Biotech Jim-5/26/2012
1558NVS PR re Lucentis ‘PRN’ data from ARVO: siliconinvestor.comDewDiligence_on_SI-5/10/2012
1557Most likely Arcalyst will not be approved. It will be interesting to see what isMiljenko Zuanic-5/8/2012
1556So looks like this won't be approved on the 30th however market didn't rFelix B-5/8/2012
1555I was hoping for bit stronger endorsement of the efficacy with not so negative oMiljenko Zuanic-5/8/2012
1554Safety vote, is safety adequate for the proposed indication? 3 yes, 8 no. SuBiotech Jim-5/8/2012
1553Efficacy vote for Arcalyst, 6-5 in favor.Biotech Jim-5/8/2012
1552My view is that the crux of the discussion will be on efficacy. What specific pBiotech Jim-5/8/2012
1551Thanxs Jim, ...as predicted. I think that efficacy will also be seen in good liMiljenko Zuanic-5/8/2012
1550Very interesting discussions on the Arcalyst FDA review for gout today, going inBiotech Jim-5/8/2012
1549Thanks. I'm coming to the conclusion that the quality of Presentations thaIan@SI-5/7/2012
1548Hi Ian, Really, don't know what to tell you. This modified Resveratrol, LonMiljenko Zuanic-5/6/2012
1547MJ, re: Message 28128043 If I could avoid being stabbed in the eye repetitivelIan@SI-5/6/2012
1546Very entertaining presentation of CATT and IVAN. Today requirement for AMD drugMiljenko Zuanic-5/6/2012
1545Small treatment effect/benefit???…I am not sure about this. Yes, absolute magnitMiljenko Zuanic-5/5/2012
1544Not only the malignancy risk also sounds like the FDA is not impressed by efficaidos-5/4/2012
1543Documents are out. Malignancy??? fda.govMiljenko Zuanic-5/4/2012
1542Some say it won't have much of an impact forbes.comFelix B-5/3/2012
1541Results are out, uphs.upenn.edu Will need to read publication, to speculate impMiljenko Zuanic-4/30/2012
1540Am curious what the FDA will end up deciding after the panel met and how things Felix B-4/26/2012
1539Doing great, thanks. Hope the same can be said for you! Price increase, at onescaram(o)uche-4/26/2012
1538 Hi Rick, how is life treating you these days? Proverb (originated in CroatiMiljenko Zuanic-4/26/2012
1537>> "Zudija laku minjo ali cud ne"! << "Stick around,scaram(o)uche-4/26/2012
1536I like the oncologic pain indication for 475. Dramatic unmet medical need thereBiotech Jim-4/26/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News